Detection of N-nitrosamines in Pharmaceutical Products

LC-MS

Detection of N-nitrosamines in Pharmaceutical Products

23 May, 2023

Published over 3 years ago. See the latest and most current information on LC-MS.

HPLC-APCI-MS/MS is a method that combines high-performance liquid chromatography (HPLC) with atmospheric pressure chemical ionisation mass spectrometry (APCI-MS/MS) to detect and quantify N-nitrosamines in pharmaceutical products.

HPLC is a chromatographic technique that separates and identifies individual components in a mixture, while APCI-MS/MS is a mass spectrometric technique that ionises and fragments molecules to detect and identify specific compounds. Combining the two techniques allows for highly sensitive and specific detection of N-nitrosamines in pharmaceutical products.

This method involves first extracting N-nitrosamines from the pharmaceutical product using a suitable solvent. The resulting solution is then injected into an HPLC system, which separates the N-nitrosamines from other components in the sample. The separated N-nitrosamines are then ionized using APCI and the resulting ions are detected using mass spectrometry. The specificity of the method is further enhanced by using tandem mass spectrometry (MS/MS), which allows for the detection of specific N-nitrosamines with high accuracy and precision.

The HPLC-APCI-MS/MS method is highly sensitive and specific, making it an effective tool for the detection and quantification of N-nitrosamines in pharmaceutical products. Its use is now more important than ever given the recent increase in recalls due to N-nitrosamine contamination. Regulatory agencies around the world are now requiring that pharmaceutical manufacturers test their products for N-nitrosamines, and the HPLC-APCI-MS/MS method is one of the most reliable and widely accepted methods available.

In summary, the HPLC-APCI-MS/MS method is a highly sensitive and specific technique that can detect and quantify N-nitrosamines in pharmaceutical products. Given the potential health risks associated with N-nitrosamines, their detection and quantification is vital to ensure the safety and quality of pharmaceutical products, and the HPLC-APCI-MS/MS method is an important tool in this regard.

Latest News

Explore Our Other Sites

Labmate Online
Portable fluorescence reader could bring forward molecular tests for use at home
Explore more Arrow
Envirotech Online
England's rivers and lakes: what the 2025 data really shows about pollution drivers
Explore more Arrow
Pollution Solutions Online
Leading UK biogas operator places first orders for new FlowSep technology
Explore more Arrow
Petro Online
EU E20 plans could create a new testing workload for fuel laboratories
Explore more Arrow